Does atorvastatin 80 mg/d reduce recurrent ischemic events in patients with acute coronary syndrome?
Early initiation of high-dose atorvastatin (80 mg/d) in patients with acute coronary syndrome reduces recurrent ischemic events within 16 weeks.
For patients with acute coronary syndrome, lipid-lowering therapy with atorvastatin, 80 mg/d, reduces recurrent ischemic events in the first 16 weeks, mostly recurrent symptomatic ischemia requiring rehospitalization.
Gregory G. Schwartz (Wed,) studied this question.